Yu Pengchun, Tung Joe K, Simons Michael
Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, New Haven, CT 06520, United States.
Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, New Haven, CT 06520, United States; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, United States.
Microvasc Res. 2014 Nov;96:10-5. doi: 10.1016/j.mvr.2014.07.016. Epub 2014 Aug 15.
Lymphatic vessels are intimately involved in the regulation of water and solute homeostasis by returning interstitial fluid back to the venous circulation and play an equally important role in immune responses by providing avenues for immune cell transport. Defects in the lymphatic vasculature result in a number of pathological conditions, including lymphedema and lymphangiectasia. Knowledge of molecular mechanisms underlying lymphatic development and maintenance is therefore critical for understanding, prevention and treatment of lymphatic circulation-related diseases. Research in the past two decades has uncovered several key transcriptional factors (Prox1, Sox18 and Coup-TFII) controlling lymphatic fate specification. Most recently, ERK signaling has emerged as a critical regulator of this transcriptional program. This review summarizes our current understanding of lymphatic fate determination and its transcriptional controls.
淋巴管通过将组织间液回流至静脉循环,密切参与水和溶质稳态的调节,并在免疫反应中发挥同样重要的作用,为免疫细胞运输提供途径。淋巴管系统的缺陷会导致多种病理状况,包括淋巴水肿和淋巴管扩张。因此,了解淋巴管发育和维持的分子机制对于理解、预防和治疗与淋巴循环相关的疾病至关重要。过去二十年的研究发现了几个控制淋巴管命运特化的关键转录因子(Prox1、Sox18和Coup-TFII)。最近,ERK信号通路已成为这一转录程序的关键调节因子。本综述总结了我们目前对淋巴管命运决定及其转录调控的理解。